Location: New York, NY
CIK: 0001278387 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $1.419B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IMDX | INSIGHT MOLECULAR DIA INC | 11,931,839 (+4.6%) | $39.14M (-54.3%) | 2.8% | $3.10 | +111.7% | COM NEW | 68235C206 |
| STAA | STAAR SURGICAL CO | 16,123,842 (+7.4%) | $302M (-13.1%) | 21.3% | $16.78 | +15.9% | COM PAR $0.01 | 852312305 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UAL | UNITED AIRLS HLDGS INC | 150,000 | $16.77M | 1.2% | — | — | CALL | 910047109 |
| AAL | AMERICAN AIRLS GROUP INC | 820,000 | $12.57M | 0.9% | — | — | CALL | 02376R102 |
| LUV | SOUTHWEST AIRLS CO | 183,000 | $7.563M | 0.5% | — | — | CALL | 844741108 |
| GIL | GILDAN ACTIVEWEAR INC | 112,750 | $7.042M | 0.5% | — | — | CALL | 375916103 |
| DAL | DELTA AIR LINES INC DEL | 52,500 | $3.643M | 0.3% | — | — | CALL | 247361702 |
| SER | SERINA THERAPEUTICS INC | 54,484 | $104K | 0.0% | $14.17 | -83.3% | — | 81751A108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MNST | MONSTER BEVERAGE CORP NEW | 8,107,796 (-1.1%) | $587M (-6.5%) | 41.4% | $36.99 | +118.0% | COM | 61174X109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXON | AXON ENTERPRISE INC | 693,504 | $295M | 20.8% | $27.50 | +1816.0% | COM | 05464C101 |
| LCTX | LINEAGE CELL THERAPEUTICS INC | 49,560,992 | $78.31M | 5.5% | $0.98 | +73.1% | COM | 53566P109 |
| IWM | ISHARES TR | 474,920 | $118M | 8.3% | $112.69 | — | RUSSELL 2000 ETF | 464287655 |